IONS logo

IONS Ionis Pharmaceuticals, Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$26.58
-0.64 (-2.35%)

Founded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapies within the United States. Its commercial portfolio includes three key medications: SPINRAZA, prescribed for spinal muscular atrophy (SMA) in both children and adults; TEGSEDI, an injectable treatment targeting …

Market Cap: $4.43Bwww.ionis.com

Price

$56.56-24.34%
$51.77$63.29$74.81$86.33
Apr 30Aug 7

Social Signal Score

48
5d
58
4 mentions
+0.0%
30d
43
20 mentions
+0.0%
60d
44
22 mentions
+0.0%
90d
45
42 mentions
+0.0%
news: 27 · rss: 12 · marketaux: 3

Analyst Ratings

33 analysts
Buyconsensus
Strong Buy 1Buy 20Hold 12Sell 0Strong Sell 0
Avg price target$78.13+193.9%
Low $53Median $82.5High $115
Current Consensus

Revenue

$242.72M+51.37%
$111.61M$238.97M$366.32M$493.68M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-2.28
$-2.59–$-1.95
6 analysts
FY2026
$-3.41
$-3.52–$-3.32
11 analysts
FY2027
$-3.16
$-7.12–$-1.07
11 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Brett Monia
Sector
Healthcare
Industry
Biotechnology
Employees
1,480
Beta
0.40
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
0.20
www.ionis.com